Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28255001.
- Also identified by DOI 10.1681/ASN.2016070734 and PMC identifier 5373463.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The renin-angiotensin system (RAS) has a pivotal role in the maintenance of extracellular volume homeostasis and blood pressure through complex mechanisms. Apart from the well known systemic RAS, occurrence of a local RAS has been documented in multiple tissues, including the kidney. A large body of recent evidence from pharmacologic and genetic studies, particularly those using various transgenic approaches to manipulate intrarenal levels of RAS components, has established the important role of intrarenal RAS in hypertension. Recent studies have also begun to unravel the molecular mechanisms that govern intrarenal RAS activity. This local system is under the control of complex regulatory networks consisting of positive regulators of (pro)renin receptor, Wnt/<i>β</i>-catenin signaling, and PGE<sub>2</sub>/PGE<sub>2</sub> receptor EP<sub>4</sub> subtype, and negative regulators of Klotho, vitamin D receptor, and liver X receptors. This review highlights recent advances in defining the regulation and function of intrarenal RAS as a unique entity separate from systemic angiotensin II generation.
Medical subject headings
- Kidney
- Renin-Angiotensin System